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1 Equal contributions.NRF2 is a well-known, master transcription factor (TF) of oxidative and xenobiotic stress responses.
Recent studies uncovered an even wider regulatory role of NRF2 inﬂuencing carcinogenesis, inﬂam-
mation and neurodegeneration. Prompted by these advances here we present a systems-level
resource for NRF2 interactome and regulome that includes 289 protein–protein, 7469 TF–DNA
and 85 miRNA interactions. As systems-level examples of NRF2-related signaling we identiﬁed reg-
ulatory loops of NRF2 interacting proteins (e.g., JNK1 and CBP) and a ﬁne-tuned regulatory system,
where 35 TFs regulated by NRF2 inﬂuence 63 miRNAs that down-regulate NRF2. The presented net-
work and the uncovered regulatory loops may facilitate the development of efﬁcient, NRF2-based
therapeutic agents.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
NRF2 (NF-E2-related factor 2, NFE2L2) is a master transcription
factor involved in oxidative and xenobiotic stress responses [1].
NRF2 features a Cap ‘‘n’’ collar (CNC) basic leucine zipper (bZIP)
structure that enables NRF2 to form heterodimer with the ZIP
domain of small MAF proteins [2]. NRF2 has six conserved
domains, designated as Neh1–6 (Nrf2-ECH homology) domains
[3]. The complex domain structure allows NRF2 to bind to DNA
and to multiple proteins including other transcription factors, the
helicase- and chromodomain containing co-activator CHD6, the
CREB-binding protein (CBP), and KEAP1, the major negative regula-
tor of NRF2 [4–6]. NRF2 also contains several lysine and serine res-
idues that serve as regulatory target sites for ligases and kinases,
respectively [3].
Under normal conditions,NRF2 is inhibitedbyKEAP1.Whencells
are exposed to oxidative stress, electrophiles, or chemopreventive
agents, NRF2 escapes KEAP1-mediated repression, enters thechemical Societies. Published by E
rcsmáros).nucleus, forms a heterodimer with its obligatory partner MAF, and
activates antioxidant responsive element (ARE)-dependent gene
expression tomaintain cellular redox homeostasis [3]. The cytopro-
tective role of NRF2 involves a cross-talk with other cellular pro-
cesses. As an example of this the p53-regulated p21 directly
activates NRF2 and promotes cell survival [7]. A key apoptosis and
autophagy regulating signaling adaptor, p62 also induces NRF2 by
inhibiting the basal KEAP1 repression [7]. Signaling pathways possi-
bly involved in the regulation ofNRF2 includeMAPKs (mitogen-acti-
vatedproteinkinases), PI3K (phosphatidylinositol 3-kinase), protein
kinase C (PKC) and CK2 (casein kinase 2) related pathways [8]. Acti-
vation of NRF2 is a well-known adaptive response to environmental
and endogenous stresses. Recent studies uncovered that NRF2 inﬂu-
ences a wide range of physiologic and pathologic processes such as
inﬂammation, carcinogenesis, chronic obstructive pulmonary dis-
ease, obesity, and neurodegeneration [9].
Despite thewide range of NRF2-driven processes, the interactors
and regulators of NRF2 have not been studied at the systems-level.
While there are more than 2300 articles for the keyword ‘NRF2’ in
PubMed (as of January 2012), major protein–protein interaction
resources (BioGRID, MINT, STRING, HPRD) contain only a few
(10–20) interactors for NRF2. Besides one study on the globallsevier B.V. All rights reserved.
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and a speciﬁc network modeling approach on Nrf2 regulation in
mouse lung [11], there is no large-scale collectionofNRF2-regulated
target genes. Prompted by the lack of systems-level NRF2-related
informationwe collected literature information onNRF2 interacting
proteins and regulated genes, as well as predicted novel NRF2 inter-
actors and regulators. Moreover, we compiled a list of potential
NRF2 regulating transcription factors andmiRNAs (i.e., NRF2 regulo-
me). Finally, we imported datasets from external sources to achieve
higher coverage and benchmark the collected database. This data-
base allowed us to examine network motifs and regulatory loops
[12] in theNRF2 interactomeand regulome (Fig. 1a). NRF2 is a prom-
ising anticancer agent, and its unregulated activation enhances tu-
mor cell protection against chemotherapy [13]. Thus, the detailed
understanding of the complexity of NRF2 interactomeand regulome
may ﬁne-tune NRF2-related anticancer approaches.
2. Materials and methods
2.1. Building the NRF2 interactome and regulome
For the manual curation of the NRF2 interactome, we applied a
curation protocol which is similar to the one that we havea
b
Fig. 1. Components and interaction types of the NRF2 interactome and regulome. (a) Stru
Regulators of NRF2 are shown with blue color. Purple arrows highlight the number of tho
the source types used to build the NRF2 interactome. Numbers represent the number of
represent the following sources: BioGRID, MINT, IntACT, HPRD and Innate DB. ‘‘Predict
notes that from the 125 predicted interactions we found 13 already described in the litpreviously developed for the manual curation of 8 major signaling
pathways in 3 organisms [14]. To identify additional interactors for
NRF2, we predicted protein–protein interactions based on possible
domain–domain and domain–motifs interactions. The protocol
which was applied during the manual curation and the details of
the predictions can be found in Supplementary Material 1. We
downloaded additional NRF2 interactions already deposited in Bio-
GRID, MINT, HPRD and IntAct by using the webservice of Pathway-
Commons [15]. As NRF2 is important in the inﬂammation process
[9], we also downloaded its interactors and target genes from
InnateDB [16]. To predict target genes regulated by NRF2, we ap-
plied the transcription factor binding site (TFBS) information of
NRF2 from JASPAR [17]. We also included all experimentally veri-
ﬁed NRF2 target genes from a large-scale ChIP-Seq proﬁling study
[10]. In order to predict transcription factors (TFs) that directly reg-
ulate NRF2 transcription, we applied a reverse approach, and que-
ried the regulatory region of the NRF2 gene sequence against all
TFBS information found in JASPAR [17]. Additionally, we acquired
the list of miRNAs predicted to regulate NRF2 mRNA from miRBase
[18]. Finally, we mined the resources TransMir and PutMir [19,20]
to identify those TFs that regulate the transcription of miRNAs
known to regulate NRF2 (acquired at the previous step from
miRBase).cture of the database with the numbers of the components and the regulatory loops.
se target genes that regulate NRF2 (termed as regulatory loops). (b) Venn-diagram of
NRF2 interactions/interactors from the given source type. The ‘‘imported databases’’
ions’’ represent both domain–motif and domain–domain interactions. The asterisk
erature (but not found during the manual curation step).
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3.1. The NRF2 interactome
We created a high-deﬁnition (HD) NRF2 interactome by manu-
ally curating the literature. This HD interactome contains 108 pro-
teins, 131 directed and 15 undirected interactions (Fig. 2). Though
during the curation we also focused on KEAP1, the major regulator
of NRF2 [3], we found only 17 KEAP1-related interactions (11.6%).
We observed that the majority of the identiﬁed interactions (57%,
84) were NRF2-interactions. 42% (55) of the 131 directed interac-
tions were inhibitory, while 58% (76) were activating interactions.
We found the molecular mechanisms, for example dimerization
and phosphorylation, for 76 direct interactions from the total 146
interactions. For the remaining 70 interactions only the corre-
sponding activating or inhibiting effect were provided in the
literature. We searched for possible domain–motif and domain–
domain interactions between interacting protein pairs to predict
underlying molecular mechanisms. Based on this and earlier liter-
ature searches, we deﬁned 12 interactions as ‘predicted as direct’
and the remaining 58 as ‘indirect’. Note that some of these indirect
interactions can be direct but currently there is no literature- or
structure-based evidence to support this. Thus, the created high-
deﬁnition interactome contains NRF2-interactors with known
functional role in the NRF2 network. The HD NRF2 interactome
contains molecular details for each interaction (e.g., dimerization,Fig. 2. Manually curated network of NRF2. The high-density NRF2 interactome with inter
are shown in red color. Undirected interactions have gray color. Direct interactions are
enlarged subnetwork and Supplementary material 8 for a searchable network image.phosphorylation) and the whole dataset is available in Supplemen-
tary Material 2.
To extend the coverage of the HD interactome, we predicted and
imported additional interactors for NRF2. We identiﬁed 22 directed
and 121 undirected interactions based on domain–motif and
domain–domain interaction predictions, respectively. These inter-
actions were found probable and highly-conﬁdent by the ELM
structure ﬁlter [21] or by the PRINCESS PPI-evaluation tool [22],
respectively. For the PRINCESS evaluation we deﬁned a very strin-
gent conﬁdence value at 1000 to ﬁlter the total 1427 predicted PPIs
to 121 highly-conﬁdent interactions. Furthermore, we checked the
literature and found 13 domain–motif and 14 domain–domain
interactions validating the predictions. Thus, the remaining 9 and
107 interactions can be considered as 116 newly predicted
NRF2-interactions. Another extension for the NRF2 interactome
was the integration of 28 interactions from PPI databases and 20
interactions from InnateDB. We note that for the predicted and
imported interactors less functional details are available compared
to the interactors in the HD interactome. But these additional inter-
actions could point out less known interactors, whose experimental
analysis may help the understanding of the pleiotropic function of
NRF2. The integrated NRF2 interactome can be found in Supplemen-
tary Material 3.
To benchmark the links of the integrated NRF2 interactome we
compared all interactions from the different sources. We found 6
interactions present in three sources and 18 in two sources. Twoactions among NRF2 interactors. Activation links are shown in green, inhibitory links
presented with solid lines, indirect interactions with dashed lines. See Fig. 4 for an
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found 224 identical interactions (i.e., interactors) for NRF2 from
the different sources (Fig. 1b). The low overlap between the man-
ually curated and imported interactions shows that the currently
existing databases lack most of the interactions that have already
been described in the literature. The high number of high-conﬁ-
dence predictions without any overlap with the other sources indi-
cates many possible novel interactors. In addition, the overlap
between the predicted and the experimentally described interac-
tors (found in manual curation and in PPI databases) shows that
10% of the predictions have already been validated.
3.2. Functional analysis of the NRF2 interactome
We analyzed the GO biological processes [23] of the NRF2 inter-
actors both in the HD and the integrated NRF2 interactome, and
found 8 major processes. As we found the same ranks for the
two interactomes (p = 1; Wilcoxon ranksum test), we present the
analysis on the HD interactome in detail (Fig. 3). In the HD interac-
tome approximately 30–35 interactors of NRF2 were involved in
the same 5 processes; that is, signaling, stress, response to chemi-
cal stimulus, metabolism and development. Except development
these major functions are generally known for NRF2 [7]. These
analyses showed that one-third of the NRF2 interactors were
highly multifunctional. Furthermore, we found 27 proteins in-
volved in the immune system with smaller overlap with the other
processes, as well as 15 and 16 interactors involved in reproduc-
tion and wound healing, respectively. The dataset and enrichment
statistics used for the functional analysis can be found in Supple-
mentary Material 4.
In spite of the high number of NRF2 interactors having develop-
mental functions (42 proteins), there is no exact description on the
role of NRF2 in mammalian development. In 1996, Chan et al. [24]
showed that NRF2 is not essential in developmental processes but
later this have been challenged [25–27]. SKN-1, the Caenorhabditis
elegans ortholog of NRF2, is known to be important in the meso-
derm and endoderm formation [28]. SKN-1 was found to be in-
volved in oocyte maturation [29], while NRF2 have recently been
described to take part in spermatogenesis [30], suggesting the
importance of NRF2 in reproduction; however, reproduction is
not yet among the GO annotations of NRF2. Similarly, immune-re-
lated processes are also missing from the GO annotations of NRF2
though 32% of the NRF2 interactors have immune functions and
NRF2 is known to be involved in innate immunity [16]. We and
others recently proved the role of SKN-1 in the pathogen response
of C. elegans suggesting a high-level functional similarity between
NRF2 and SKN-1 [31,32].Fig. 3. Functional overlap in the NRF2 interactome. The 8 major Gene Ontology Biolo
diagonal represent the total number of the NRF2 interactors involved in the given function
The colors of the cells illustrate the level of the overlap between the functional groups. T
are not among the NRF2 Gene Ontology terms (see Supplementary material 4. for the w3.3. The NRF2 regulome
NRF2 expression is regulated by transcription factors (TF) and
miRNAs. Accordingly, we predicted 34 TFs that could regulate the
expression of NRF2 based on TF–TFBS binding data from JASPAR
[17]. We checked the literature and found 11 predicted TFs
(MEF2A, ESR1, ESR2, NF-kappaB, PPARG, SP1, NFE2L2 and the TF-
complexes MYC-MAX, EWSR1-FLI1) which are already known to
regulate NRF2 showing that the prediction algorithm can indeed
identify valuable regulatory connections. The remaining 24 pre-
dicted TFs, such as FOXA1, STAT1, PAX6 can be regarded as prom-
ising novel regulators for experimental validation. The miRBase
resource [18] contained 85 identical miRNAs predicted to bind to
NRF2 mRNA and down-regulate its translation. Thus, we found
altogether 34 TFs and 85 miRNAs that could directly regulate the
expression of NRF2 (for a complete list, see Supplementary Mate-
rial 5). Till now, regulation of NRF2 was mostly considered as a
post-translational mechanism via KEAP1 [3]. Here, we point out
numerous TFs that may be involved in the regulation of the expres-
sion of NRF2 and these TFs could be important in the basal function
of NRF2 [10] as well as in the long-time effect of NRF2 upon induc-
tion. Down-regulating NRF2 by miRNAs have already been de-
scribed for a few miRNAs (e.g., miR-28, miR-144) and the
malfunction of this regulation is linked to different pathological
states [33,34]. The predicted NRF2 regulators need to be analyzed
experimentally under normal and in diseased conditions to vali-
date the prediction.
We also collected the target genes of NRF2. First, by manual
curation we found 29 NRF2 target genes in the literature. We ex-
tended this list by including 6 target genes from the manually cu-
rated InnateDB and 1054 genes identiﬁed in a large-scale ChIP-Seq
study [10]. Based on TF–TFBS binding data from JASPAR [17], we
further predicted 6426 NRF2 target genes. We found some overlaps
between the compiled 7515 target genes: while no genes present
in all four sources, we found 1 target gene (COX6C) in three sources
(manual curation, ChIP-Seq, JASPAR), and 44 target genes in two
sources. Thus, altogether we found 7469 identical target genes
for NRF2 from which 7424 target genes were found only by one
source. The small overlap among the sources, especially between
the large-scale ChIP-Seq study and the JASPAR prediction was sur-
prising but can be explained by checking the details of these meth-
ods. The examined sequence regions were much broader in the
prediction (see Supplementary Material 1) and the ChIP-Seq study
contained only conﬁdent, functional and NRF2-speciﬁc target se-
quences [10]. Thus, the prediction may contain non-functional
NRF2 binding sites but it may also list those binding sites that
are bound by NRF2 in complex with other transcription factorsgical Processes are shown among the NRF2 interactors. The numbers in the main
, while the numbers in the matrix represent the overlap between the given function.
wo functions, ‘‘immune system’’ and ‘‘reproduction’’ is highlighted with red as they
hole dataset and functional analysis).
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Seq study only listed target genes whose expression was positively
regulated by NRF2 [10], while the predicted set may contain nega-
tively regulated genes. Detailed expression studies will be neces-
sary to determine the effect of NRF2 on the expression of these
possible target genes.
Combining the upstream and downstream components of the
NRF2 regulatory network resulted in an integrated regulome, con-
taining the regulators as well as the regulated genes of NRF2. The
integrated regulome can be found in Supplementary Material 5.
3.4. Interaction and regulatory loops
Using the developed integrated resource for NRF2, we searched
for networkmotifs, i.e., loops among the interacting proteins, target
genes and NRF2 regulating TFs, and miRNAs. In the high-density
interactomewe found 7 bidirectional interactions (i.e., two-compo-
nent feedforward and feedback-loops) between NRF2 and 7 of its
interactors (BRCA1, KEAP1, NFE2, BACH1, ATF4, CUL3, NCOR1). In
the same network we identiﬁed 23 three-component feedfor-
ward-loops among NRF2 and its 27 interactors (Fig. 4). In nearly
all feedforward-loops NRF2 is located at the ﬁnal, executive posi-
tion, suggesting that there are several mechanisms that regulate
NRF2 directly and also indirectly. When the signal (e.g., activation)
is the same – in both direct and indirect mechanisms – then NRF2
will coherently and functionally ‘correctly’ act; on the other hand,
when the signal is incoherent (e.g., a direct inhibition followed by
an indirect activation) it could modulate and adapt its activity for
the speciﬁc functional requirements [35]. For example, the loop
containing CK2, KEAP1 and NRF2 is such an incoherent feedforward
loop. Here, CK2 fulﬁls a key role in the control of NRF2 as it directly
inhibits NRF2 only under speciﬁc conditions [36]. Interestingly, weFig. 4. Feedforward loops in the manually curated NRF2 interactome. The subnetwork of
links are shown with delta arrows, inhibitory links with T-arrows, while undirected inte
interaction with dashed lines. Note the 4 smaller loops marked with different colors on th
(orange) and NF-kB (green) on the right side, enlarged in colored boxes.found no three-component feedback loops in the interactome sug-
gesting that this important regulatory mechanism is not character-
istic to the NRF2-related protein network.
We combined the list of NRF2 interactors from the integrated
interactome and the list of NRF2 target genes from the integrated
regulome to identify two-component regulatory feedback-loops
between them. We found 39 proteins that interact with NRF2
and their expression is regulated by NRF2 (Supplementary Material
6). For example, JNK1 can phosphorylate NRF2, which induces its
translocation into the nucleus, where NRF2 transcriptionally in-
duces the expression of stress-responsive genes [37] that include
the JNK1 itself [38] (Fig. 5a). Similarly, p300/CBP, an important
transcriptional co-activator, directly acetylates NRF2 which aug-
ments its promoter-speciﬁc DNA binding [39]. As an extension of
our current knowledge on the CBP-NRF2 connection, we predicted
that NRF2 can regulate the expression of CBP (Fig. 5b). In conclu-
sion, nearly 20% (39 of 224) of the NRF2 interacting proteins have
regulatory feedback connections with NRF2. This feedback mecha-
nism could serve as ampliﬁcation (in the case of a positive feed-
back) or signal down-regulation (in the case of a negative
feedback). Based on available microarray data [10,40,41] and de-
tails on the NRF2 interactions, we found 10 positive and 3 negative
feedback loops (listed in Supplementary Material 6). For the
remaining 26 feedbacks, no data were available on the transcrip-
tional effect of NRF2 on its target genes (activation or inhibition)
or on the role of the protein interacting with NRF2. Further studies
are needed to determine the effect of these interactions. Experi-
mental analysis of the identiﬁed 13 feedback loops would help to
understand their regulatory functions in the cellular network.
A similar search of the NRF2 regulating TFs and NRF2 target
genes identiﬁed 3 TFs, the nuclear hormone receptors PPARc and
RORA, and the transcription factor, NFIL3 forming 3 regulatorythe HD NRF2 interactome containing only feedforward interaction loops. Activation
ractions have no arrows. Direct interactions are presented with solid lines, indirect
e left side of the image and the more complex intertwined motif-system with KEAP1
a b
c
Fig. 5. NRF2 regulatory loops. (a) The regulatory loop of NRF2 and JNK1. (b) The regulatory loops of NRF2 and CBP, where the NRF2 regulation is predicted. (c) The mutual
regulatory loop between NRF2 and PPARc.
1800 D. Papp et al. / FEBS Letters 586 (2012) 1795–1802loops with NRF2 (Fig. 1a). NRF2 binds to the promoter of PPARc
and stimulates its transcription [42]. PPARc and NRF2 have already
been predicted to form a mutual feedback regulation [43]. We also
note that PPARc can directly interact with NRF2 [44] indicating a
more complex regulatory mechanism between the two TFs
(Fig. 5c). We found no literature evidence on any connections be-
tween NRF2 and NFIL3 or between NRF2 and RORA. Thus, these
regulatory loops are lucrative targets for further experimental
inquiries. The major function of NFIL3 is to transcriptionally regu-
late genes important in the immune response [45]. The mutual
feedback loop between NRF2 and NFIL3 may point out an impor-
tant cross-talk between the anti-oxidant and immune responses.
RORA is a multi-functional protein that bridges inﬂammation and
metabolism [46]. The mutual feedback loop between NRF2 and
RORA could bi-directionally coordinate the changes of cellular pro-
cesses during inﬂammation.
Finally, we searched for three-component regulatory loops
among NRF2 regulating miRNAs, the TFs that regulate these miRNA
and NRF2 target genes. We found 164 TFs that regulate NRF2 regu-
lating miRNAs. The comparison with the NRF2 target genes showed
35 TFs, whose expression is regulated by NRF2 while they regulate
altogether 63 miRNAs that down-regulate NRF2 (Fig. 1a). We found
that the transcription of 18 TFs (from the 35) is activated by NRF2
with no data for the remaining 17 TFs. Altogether 74% (63 of 85)
of the NRF2-regulatingmiRNAs could serve as feedback loops. Com-
bining available data on the transcriptional effects of NRF2 and the
miRNA regulating TFs, we found only 1 TF, TWIST1 that represses a
possible anti-NRF2miRNA (miR-200a), while the other TFs possibly
activate the miRNAs. Therefore, most of the regulatory loops serve
as a negative feedback for NRF2 (activating a TF that activates a
down-regulatingmiRNA) but positive feedback loops can also exist,
where the activated TF represses a down-regulating miRNA. Thedifference between the number of simple TF-loops (containing 3
TFs) and the more complex, miRNA-loops (containing 336 possible
loops between 35 TFs and 63 miRNAs) point to a ﬁne-tuned NRF2-
regulatory system. We believe that the complexity of this regula-
tory system allows tissue and stress speciﬁc responses as well as
the integration of the NRF2-related responses to other cellular pro-
cesses. Similar systems have already been suggested for other mas-
ter TF regulators, such as DAF-16/FOXO and the heat shock factor
HSF-1 [47–49]. Dynamical expression studies on the key 63, NRF2
regulating miRNAs might uncover this mechanism. We listed all
regulatory loops in Supplementary Material 7.
4. Conclusions
We developed a systems-level resource for NRF2, containing
manually curated, predicted and imported physical as well as reg-
ulatory interactions. All data sources can be examined separately
with their corresponding available evidence or conﬁdence scores.
These allow the users selection of data types and conﬁdence levels.
As our manual curation contained more than three times the num-
ber of interactions for NRF2 than the already existing databases,
and 81% of the predicted interactions are novel, we believe that
our compilation could provide an efﬁcient resource for the bio-
medical research on NRF2. This resource could facilitate network
pharmacological attempts [50], including a multi-target concept
[51,52] and the recently proposed allo-network drug concepts
[53] and may help to overcome challenges in targeting NRF2 which
is a double-edged sword in many diseases; that is, the activation of
NRF2 in healthy cells could delay or prevent the onset of some
forms of human cancers [54], while its constitutive activation is
responsible for acquired chemoresistance in tumor cells [13,55].
Thus, we believe that a more detailed, dynamical understanding
D. Papp et al. / FEBS Letters 586 (2012) 1795–1802 1801of the NRF2 interactome, regulome and ﬁne-tuned regulatory loops
will help to develop more potent NRF2 activator and inhibitor ther-
apeutic agents.
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